Wonbiogen Co., Ltd. (KOSDAQ: 307280)
1,355.00
-15.00 (-1.09%)
Sep 11, 2024, 3:00 PM KST
Wonbiogen Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 4,562 | 5,497 | 3,206 | -716.2 | -11,662 |
Depreciation & Amortization | 1,643 | 1,569 | 1,199 | 881.58 | 731.27 |
Loss (Gain) From Sale of Assets | 14.23 | 7.13 | -11.69 | 57.7 | - |
Loss (Gain) From Sale of Investments | -48.67 | -48.67 | 200 | - | - |
Loss (Gain) on Equity Investments | 52.26 | 60.51 | - | - | - |
Stock-Based Compensation | - | - | - | 8.11 | 18.07 |
Provision & Write-off of Bad Debts | -119.04 | 246.2 | 408.88 | 524.98 | 3.65 |
Other Operating Activities | 1,341 | 938.55 | 1,960 | 2,641 | 13,632 |
Change in Accounts Receivable | -1,428 | -2,521 | -224.68 | -256.06 | -1,754 |
Change in Inventory | -197.14 | -1,215 | -936.87 | -2,361 | -221.81 |
Change in Accounts Payable | 128.73 | 452.82 | -133.58 | 741.99 | -38.82 |
Change in Unearned Revenue | -0.53 | 23.12 | -46.45 | 16.16 | - |
Change in Income Taxes | - | - | - | 31.85 | - |
Change in Other Net Operating Assets | 103.99 | -175.27 | 161.35 | -487.8 | 89.31 |
Operating Cash Flow | 6,052 | 4,835 | 5,782 | 1,082 | 798.06 |
Operating Cash Flow Growth | -9.39% | -16.38% | 434.37% | 35.58% | - |
Capital Expenditures | -1,541 | -1,646 | -6,494 | -2,336 | -679.28 |
Sale of Property, Plant & Equipment | 116.4 | 121.73 | 0.12 | 1,050 | - |
Sale (Purchase) of Intangibles | -87.78 | -88.39 | -74.16 | -1.96 | -12.57 |
Investment in Securities | -946.45 | -775.82 | 723.24 | -1,098 | -40.52 |
Other Investing Activities | 48.14 | 22.14 | -6.78 | -95.43 | -0.45 |
Investing Cash Flow | -2,372 | -2,589 | -5,852 | -2,481 | -732.82 |
Short-Term Debt Issued | - | 500 | 59.89 | - | 1,000 |
Long-Term Debt Issued | - | 500 | - | 7,984 | 20 |
Total Debt Issued | 500 | 1,000 | 59.89 | 7,984 | 1,020 |
Short-Term Debt Repaid | - | -500 | -59.89 | -1,420 | - |
Long-Term Debt Repaid | - | -2,797 | -303.66 | -240.47 | -1,038 |
Total Debt Repaid | -3,806 | -3,297 | -363.55 | -1,660 | -1,038 |
Net Debt Issued (Repaid) | -3,306 | -2,297 | -303.66 | 6,324 | -17.92 |
Issuance of Common Stock | 178.34 | 218.33 | - | 411.26 | - |
Repurchase of Common Stock | - | - | -2,996 | - | - |
Dividends Paid | -709.19 | -349.55 | - | - | - |
Other Financing Activities | -0.64 | -1.32 | -1,000 | -163.81 | 10 |
Financing Cash Flow | -3,837 | -2,429 | -4,300 | 6,571 | -7.92 |
Foreign Exchange Rate Adjustments | 11.32 | -6.72 | -75.95 | 1.2 | -17.12 |
Miscellaneous Cash Flow Adjustments | - | - | - | 1,302 | - |
Net Cash Flow | -146.72 | -189.86 | -4,445 | 6,476 | 40.2 |
Free Cash Flow | 4,510 | 3,189 | -711.95 | -1,254 | 118.77 |
Free Cash Flow Margin | 15.35% | 10.77% | -2.66% | -7.08% | 0.99% |
Free Cash Flow Per Share | 120.40 | 83.86 | -19.79 | -36.10 | 5.11 |
Cash Interest Paid | 82.57 | 83.89 | 27.55 | 17.96 | -11.4 |
Cash Income Tax Paid | 1,191 | 1,041 | -55.27 | 222.5 | 602.46 |
Levered Free Cash Flow | 3,822 | 1,293 | -4,009 | -16,614 | - |
Unlevered Free Cash Flow | 3,893 | 1,366 | -3,213 | -16,345 | - |
Change in Net Working Capital | 147.61 | 2,867 | 999.94 | 16,165 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.